Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2023-06-15
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Regular exercise sessions incorporating balance, resistance training, and walking to accommodate diminished endurance, with synergistic protein and nutritional supplementation
Multicomponent (Exercise + Protein Supplementation)
* Exercises selected from a pre-specified list, reassessed weekly
* Participants will receive individualized exercise sessions, (e.g. 15-30 minutes per session, one session per day, offered five times a week)
* Participants will also be offered a protein supplement within 30 min of exercise.
* Sessions will be supervised
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multicomponent (Exercise + Protein Supplementation)
* Exercises selected from a pre-specified list, reassessed weekly
* Participants will receive individualized exercise sessions, (e.g. 15-30 minutes per session, one session per day, offered five times a week)
* Participants will also be offered a protein supplement within 30 min of exercise.
* Sessions will be supervised
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 65 years
* Admitted to SNF directly from inpatient hospitalization
* English speaking
* Mild Frailty or worse, as measured by a Clinical Frailty Scale
Exclusion Criteria
* Non-community discharge plan on admission (e.g. plan to discharge to hospice)
* Nothing per oral (NPO) dietary status
* Presence of any feeding tube
* Chronic kidney disease stage IV or worse
* Clinician refusal
* Inability or refusal to consume intervention products (e.g. allergies to protein supplement)
* Inability to consent to study procedures
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hebrew SeniorLife
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandra Shi
Instructor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandra Shi, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Hebrew SeniorLife
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hebrew Rehabilitation Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00068129
Identifier Type: -
Identifier Source: org_study_id